WAY 207024 dihydrochloride

GnRH-R antagonist, potent CAS# 872002-73-8

WAY 207024 dihydrochloride

Catalog No. BCC7802----Order now to get a substantial discount!

Product Name & Size Price Stock
WAY 207024 dihydrochloride: 5mg $150 In Stock
WAY 207024 dihydrochloride: 10mg Please Inquire In Stock
WAY 207024 dihydrochloride: 20mg Please Inquire Please Inquire
WAY 207024 dihydrochloride: 50mg Please Inquire Please Inquire
WAY 207024 dihydrochloride: 100mg Please Inquire Please Inquire
WAY 207024 dihydrochloride: 200mg Please Inquire Please Inquire
WAY 207024 dihydrochloride: 500mg Please Inquire Please Inquire
WAY 207024 dihydrochloride: 1000mg Please Inquire Please Inquire
Related Products
  • T 98475

    Catalog No.:BCC7395
    CAS No.:199119-18-1
  • AG 045572

    Catalog No.:BCC7464
    CAS No.:263847-55-8

Quality Control of WAY 207024 dihydrochloride

Number of papers citing our products

Chemical structure

WAY 207024 dihydrochloride

3D structure

Chemical Properties of WAY 207024 dihydrochloride

Cas No. 872002-73-8 SDF Download SDF
PubChem ID 69403574 Appearance Powder
Formula C30H34Cl2N6 M.Wt 549.54
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 85 mM in DMSO
Chemical Name 6-[[4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]methyl]quinoxaline;dihydrochloride
SMILES CC(C)(C)C1=CC=C(C=C1)C2=NC3=C(N2)C=CC=C3N4CCN(CC4)CC5=CC6=NC=CN=C6C=C5.Cl.Cl
Standard InChIKey REQCNTGYEABOIT-UHFFFAOYSA-N
Standard InChI InChI=1S/C30H32N6.2ClH/c1-30(2,3)23-10-8-22(9-11-23)29-33-25-5-4-6-27(28(25)34-29)36-17-15-35(16-18-36)20-21-7-12-24-26(19-21)32-14-13-31-24;;/h4-14,19H,15-18,20H2,1-3H3,(H,33,34);2*1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of WAY 207024 dihydrochloride

DescriptionGonadotropin releasing hormone receptor (GnRH-R) antagonist. Exhibits potent affinity (IC50 values are 12 and 71 nM for human and rat GnRH receptors respectively). Lowers plasma leuteinizing hormone levels in the rat. Orally active.

WAY 207024 dihydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

WAY 207024 dihydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of WAY 207024 dihydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.8197 mL 9.0985 mL 18.197 mL 36.3941 mL 45.4926 mL
5 mM 0.3639 mL 1.8197 mL 3.6394 mL 7.2788 mL 9.0985 mL
10 mM 0.182 mL 0.9099 mL 1.8197 mL 3.6394 mL 4.5493 mL
50 mM 0.0364 mL 0.182 mL 0.3639 mL 0.7279 mL 0.9099 mL
100 mM 0.0182 mL 0.091 mL 0.182 mL 0.3639 mL 0.4549 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on WAY 207024 dihydrochloride

WAY 207024 dihydrochloride is a potent gonadotropin releasing hormone receptor (GnRH-R) antagonist with IC50 values of 12 and 71 nM for human and rat GnRH receptors, respectively [1].
GnRH-R is a member of the G-protein coupled receptor (GPCR) family. Activation of the receptor by binding of gonadotropin-releasing hormone causes the release of leuteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior pituitary gland and they in turn stimulate sex hormone synthesis and release into the general circulation [1].
WAY 207024 dihydrochloride displayed moderate membrane permeability properties and rat liver microsome stability [1].
In castrated rats, WAY 207024 dihydrochloride was absorbed well following oral administration with a bioavailability of 74%. Also, WAY 207024 dihydrochloride (30 mg/kg, oral gavage) reduced serum LH levels starting at 1 h post dosing and LH levels had returned to the vehicle treated group levels after 24h [1].
References:
[1]. Pelletier JC, Chengalvala MV, Cottom JE, et al. Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R). J Med Chem, 2009, 52(7): 2148-2152.

Featured Products
New Products
 

References on WAY 207024 dihydrochloride

Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.[Pubmed:19072222]

J Med Chem. 2009 Jan 8;52(1):214-8.

Altered peptide ligands that alter immune responses are a promising approach to the immunotherapy of multiple sclerosis. Cyclic peptides are of interest because the limited stability of linear peptides restricts their use in vivo. We designed and synthesized a cyclic double mutant peptide from MBP(87-99)-[cyclo(87-99)[A(91),A(96)]MBP(87-99)]. Immunization of mice, in CFA reduced Th1 responses. However, when conjugated to reduced mannan, a significant further reduction of Th1 responses and moderate Th2 responses were induced.

Description

GnRH receptor antagonist

Keywords:

WAY 207024 dihydrochloride,872002-73-8,Natural Products,Gonadotropin-Releasing Hormone Receptors, buy WAY 207024 dihydrochloride , WAY 207024 dihydrochloride supplier , purchase WAY 207024 dihydrochloride , WAY 207024 dihydrochloride cost , WAY 207024 dihydrochloride manufacturer , order WAY 207024 dihydrochloride , high purity WAY 207024 dihydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: